Skip to main content
. 2018 Apr 25;9:182. doi: 10.3389/fendo.2018.00182

Table 2.

Serum hormone levels in normal controls and in patients with unilateral or bilateral cryptorchidism.

1–5.9 months
6 months–1.9 years
2–8.9 years
≥9 years
Controls Unilateral Bilateral Controls Unilateral Bilateral Controls Unilateral Bilateral Controls Unilateral Bilateral
AMHa
n 24 12 7 26 28 52 95 68 97 34 16 21
Median (pmol/L) 697 931 1,145 1,132 981 563 684 682 525 713 551 580
Range (pmol/L) 418–1,939 153–1,337 153–1,417 441–2,682 405–2,061 34–1,747 207–2,761 80–1,635 31–1,400 256–1,462 147–966 43–1,175
<3rd percentile, n (%) 2 (16.7) 1 (14.3) 2 (7.1) 19 (36.5) 5 (7.2) 18 (18.6) 1 (6.3) 2 (9.5)
Kruskal–Wallis + Dunnb a a a a a b a a b a a a

FSH
n 14 12 7 11 28 52 33 66 90 17 16 21
Median (IU/L) 1.30 1.36 1.70 0.59 0.10 0.71 0.75 0.84 0.83 1.70 1.0 1.20
Range (IU/L) 0.26–2.78 0.27–6.16 0.73–2.5 0.26–1.96 0.05–2.00 0.10–2.51 0.20–3.21 0.05–3.77 0.10–2.40 0.41–2.59 0.10–2.72 0.50–7.33
>97th percentile, n (%) 1 (8.3) 0 1 (3.6) 3 (5.8) 1 (1.5) 0 1 (6.3) 4 (19.1)
Kruskal–Wallis + Dunnb a a a a a a a a a a a a

LH
n 15 12 7 11 28 52 34 67 90 17 16 21
Median (IU/L) 1.8 1.215 3.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
Range (IU/L) 0.10–4.41 0.10–8.90 0.10–12.20 0.10–0.93 0.10–2.00 0.10–1.50 0.10–0.19 0.10–0.37 0.10–1.19 0.10–3.09 0.10–0.79 0.10–1.15
>97th percentile, n (%) 1 (8.3) 2 (22.2) 1 (3.6) 3 (5.8) 7 (10.6) 6 (6.7) 0 0
Kruskal–Wallis + Dunnb a a a a a a a a a a a a

aTo obtain serum anti-Müllerian hormone (AMH) in ng/mL, divide by 7.14.

bKruskal–Wallis test followed by Dunn’s multiple comparison test (Controls vs Unilateral vs Bilateral). In each age subgroup, a different letter indicates that there is a significant difference when comparing Controls vs Unilateral vs Bilateral (P < 0.05).